MedTrace Logo

Oncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of LN Positivity

NCT04037124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 718

Last updated 2022-08-09

No results posted yet for this study

Summary

The ABRAX trial is multicentre retrospective cohort study. Included are patients with negative LN in clinical staging, in whom LN involvement is detected intraoperatively. Completion or abandonment of planned cervical procedure stratifies the cohort in two subgroups in which oncological outcome and morbidity will be compared.

The investigators hypothesise that in patients with intraoperative LN involvement, a completion of radical hysterectomy or other cervical procedure does not improve oncological outcome of definitive chemoradiation.

Conditions

  • Uterine Cervical Neoplasms

Interventions

PROCEDURE

Cervical procedure

simple hysterectomy, radical hysterectomy or fertility sparing surgery

Sponsors & Collaborators

  • General University Hospital, Prague

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04037124 on ClinicalTrials.gov